Phase II trial of thalidomide for therapy of radioiodine-unresponsive and rapidly progressive thyroid carcinomas.
作者： Kenneth B. Ain , Charles Lee , Kevin D. Williams
关键词: Pathology 、 Medicine 、 Cancer research 、 Distantly Metastatic 、 Thyroid carcinoma 、 Disease progression 、 Thalidomide
摘要: Background: There are no known effective therapies for distantly metastatic, rapidly progressive thyroid carcinomas unresponsive to radioiodine. Objective: Since hypervascula...
liebertonline.com参考文章(41)
Andrezza V. Belo, Mônica A. N. D. Ferreira, Adriana A. Bosco, Rosângela D. P. Machado, Silvia P. Andrade, Differential effects of thalidomide on angiogenesis and tumor growth in mice. Inflammation. ,vol. 25, pp. 91- 96 ,(2001) , 10.1023/A:1007114404953
Richard M. Rohan, Antonio Fernandez, Taturo Udagawa, Jenny Yuan, Robert J. D'Amato, Genetic heterogeneity of angiogenesis in mice The FASEB Journal. ,vol. 14, pp. 871- 876 ,(2000) , 10.1096/FASEBJ.14.7.871
Yehuda Z. Patt, Manal M. Hassan, Richard D. Lozano, Ajay K. Nooka, Isaac I. Schnirer, Jerome B. Zeldis, James L. Abbruzzese, Thomas D. Brown, Thalidomide in the treatment of patients with hepatocellular carcinoma: a phase II trial. Cancer. ,vol. 103, pp. 749- 755 ,(2005) , 10.1002/CNCR.20821
M.L. Douglas, J.L. Reid, S.I. Hii, J.R. Jonsson, D.L. Nicol, Renal cell carcinoma may adapt to and overcome anti-angiogenic intervention with thalidomide BJU International. ,vol. 89, pp. 591- 595 ,(2002) , 10.1046/J.1464-410X.2002.02666.X
Erin D. Bigler, Duane D. Blatter, Shanna Kurth, Sterling C. Johnson, Carol V. Anderson, Susan D. Horn, Shawn D. Gale, Bruce M. Burnett, Natalie Parker, Quantitative Volumetric Analysis of Brain MR: Normative Database Spanning 5 Decades of Life American Journal of Neuroradiology. ,vol. 16, pp. 241- 251 ,(1995)
Howard A. Fine, William D. Figg, Kurt Jaeckle, Patrick Y. Wen, Athanassios P. Kyritsis, Jay S. Loeffler, Victor A. Levin, Peter M. Black, Richard Kaplan, James M. Pluda, W.K. Alfred Yung, Phase II Trial of the Antiangiogenic Agent Thalidomide in Patients With Recurrent High-Grade Gliomas Journal of Clinical Oncology. ,vol. 18, pp. 708- 715 ,(2000) , 10.1200/JCO.2000.18.4.708
Richard F. Little, Kathleen M. Wyvill, James M. Pluda, Lauri Welles, Vickie Marshall, William D. Figg, Fonda M. Newcomb, Giovanna Tosato, Ellen Feigal, Seth M. Steinberg, Denise Whitby, James J. Goedert, Robert Yarchoan, Activity of Thalidomide in AIDS-Related Kaposi’s Sarcoma Journal of Clinical Oncology. ,vol. 18, pp. 2593- 2602 ,(2000) , 10.1200/JCO.2000.18.13.2593
Robert J. Amato, Thalidomide therapy for renal cell carcinoma. Critical Reviews in Oncology Hematology. ,vol. 46, pp. 59- 65 ,(2003) , 10.1016/S1040-8428(03)00065-9
Alessandro Morabito, Massimo Fanelli, Guido Carillio, Domenico Gattuso, Roberta Sarmiento, Giampietro Gasparini, Thalidomide prolongs disease stabilization after conventional therapy in patients with recurrent glioblastoma. Oncology Reports. ,vol. 11, pp. 93- 95 ,(2004) , 10.3892/OR.11.1.93
Kenneth S Bauer, Shannon C Dixon, William D Figg, Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent. Biochemical Pharmacology. ,vol. 55, pp. 1827- 1834 ,(1998) , 10.1016/S0006-2952(98)00046-X